Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-20 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Inflammation 2 D007249 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3301580
FDA SRS 82WG3POL9W